CoChat

Progress with YAP/TAZ-TEAD inhibitors: a patent review (2018-present)

Zagiel, Benjamin, Melnyk, Patricia, Cotelle, Philippe · 2022 · Expert Opinion on Therapeutic Patents
Cited by 50

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

INTRODUCTION: The Hippo pathway represents a new opportunity for the treatment of cancer. Overexpression of Yes-associated protein (YAP) or transcriptional coactivator with PDZ-binding motif (TAZ) or TEAD has been demonstrated in cancers and YAP mediates resistance to cancer drugs. Since 2018, the potential of this pathway has been illustrated by numerous articles and patents and the first drugs entering in clinical trial phase 1. AREAS COVERED: This review is limited to published patent applications that have disclosed direct small-molecule inhibitors of the YAP/TAZ-TEAD interaction. EXPERT OPINION: The YAP/TAZ-TEAD transcriptional complex is a promising target for the treatment of cancer. Approximately 30 international patents (used database: Sci-finder, query: TEAD; documents: patents; period: from 2017-January 2022) that disclose TEAD transcriptional inhibitors have been filled since 2018. The mechanism of action is not always described in the patents, we can divide the drugs into three different categories: (i) external TEAD ligands; (ii) non-covalent TEAD ligands of the palmitate pocket; (iii) covalent TEAD ligands, which bind into the palmitate pocket. The first molecules in clinical trial phase 1 are non-covalent TEAD ligands. The selective TEAD ligand have also been patented, published and selectivity could be of great interest for personalized medicine.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/13543776.2022.2096436

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Research works printed but not linked: 49

  1. 10.1038/nrc3876 · DOI · Paper page
  2. 10.1038/nrd4161 · DOI · Paper page
  3. 10.1002/jnr.24551 · DOI · Paper page
  4. 10.3389/fnins.2020.00595 · DOI
  5. 10.1152/physrev.00005.2014 · DOI · Paper page
  6. 10.1016/j.cmet.2018.07.010 · DOI · Paper page
  7. 10.3389/fonc.2020.01266 · DOI
  8. 10.1101/gad.1865810 · DOI · Paper page
  9. 10.1002/cbic.201300163 · DOI · Paper page
  10. 10.1111/febs.14817 · DOI
  11. 10.1021/acs.jmedchem.7b00879 · DOI · Paper page
  12. 10.1016/j.str.2015.11.005 · DOI · Paper page
  13. 10.1002/jcc.20084 · DOI · Paper page
  14. Lam-Himlin DM, 2006, Int. J. Gastrointest. Cancer, 37, 103
  15. 10.1111/pcmr.12249 · DOI
  16. 10.3892/mmr.2014.2818 · DOI · Paper page
  17. 10.1038/nature25459 · DOI · Paper page
  18. 10.1016/j.bbagrm.2016.02.010 · DOI
  19. 10.3390/cancers10040090 · DOI
  20. 10.1080/13543776.2018.1549226 · DOI
  21. 10.1016/j.chembiol.2018.11.010 · DOI · Paper page
  22. 10.1016/j.ab.2019.113413 · DOI
  23. 10.1158/1535-7163.MCT-17-0560 · DOI · Paper page
  24. 10.1016/j.celrep.2020.107809 · DOI · Paper page
  25. 10.1016/j.bmcl.2019.06.022 · DOI
  26. 10.1021/acschembio.9b00786 · DOI
  27. 10.1016/j.ejmech.2021.113835 · DOI
  28. 10.1016/j.str.2015.09.009 · DOI · Paper page
  29. Kaneda A, 2020, Am J Cancer Res, 10, 4399
  30. 10.1021/acs.jmedchem.0c01275 · DOI
  31. 10.1016/j.ejmech.2019.111767 · DOI · Paper page
  32. 10.1371/journal.pone.0045498 · DOI
  33. 10.1038/sj.bjc.6604774 · DOI
  34. Joo JS, 2020, Oncol Rep, 43, 1785
  35. 10.1242/jcs.139865 · DOI · Paper page
  36. 10.1016/j.pan.2020.12.003 · DOI
  37. 10.1016/j.bbagrm.2016.02.010 · DOI
  38. 10.1038/onc.2015.342 · DOI
  39. 10.12998/wjcc.v7.i15.1954 · doi:10.12998/wjcc.v7.i15.1954
  40. Qi Y, 2016, Nat Commun, 7
  41. 10.1016/j.cell.2007.07.019 · DOI · Paper page
  42. 10.1016/j.ccell.2021.06.016 · DOI · Paper page
  43. 10.1080/23723556.2021.1981111 · DOI
  44. 10.1038/s41467-022-28691-0 · DOI · Paper page
  45. 10.1021/acs.jmedchem.2c00075 · DOI
  46. 10.1016/j.jid.2020.01.029 · DOI
  47. 10.1016/j.ajpath.2019.01.016 · DOI
  48. 10.18632/oncotarget.11057 · DOI
  49. 10.1158/0008-5472.CAN-13-2712 · DOI · Paper page

Cited by

See all 50

Metadata

Authors
Zagiel, B., Melnyk, P., & Cotelle, P.
Venue
Expert Opinion on Therapeutic Patents
Published
2022-07-05
Volume
32
Issue
8
Pages
899-912
ISSN
  • 1354-3776 (ISSN-L)
  • 1744-7674
OpenAlex
W4283735204
Cited by
50
References
13
FWCI
4.89
Type
journal article
Language
en
Open access
closed
Funders
Ministère de l’Enseignement Supérieur, de la Recherche et de l’Innovation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Progress with YAP/TAZ-TEAD inhibitors: a patent review (2018-present). https://app.cochat.ai/papers/10.1080/13543776.2022.2096436
The paper
Zagiel, B., Melnyk, P., & Cotelle, P. (2022). Progress with YAP/TAZ-TEAD inhibitors: a patent review (2018-present). Expert Opinion on Therapeutic Patents. https://doi.org/10.1080/13543776.2022.2096436

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.